Long-term efficacy and progression patterns of paclitaxel plus cisplatin and 5-fluorouracil induction chemotherapy for locally advanced borderline-resectable esophageal squamous cell carcinoma: results from a phase II NEOCRTEC1601 study
{{output}}
Introduction: The NEOCRTEC1601 trial aimed to evaluate the efficacy and safety of paclitaxel in combination with cisplatin and 5-fluorouracil (TPF) as induction chemotherapy for BR-ESCC. This study presented an updated 5-year ana... ...
